Table 1 Baseline characteristics.

From: Hyperbaric oxygen therapy vs. pharmacological intervention in adults with fibromyalgia related to childhood sexual abuse: prospective, randomized clinical trial

 

HBOT group

Medications group

p-value

N

24

24

 

Age

32.8 ± 6.3

34.0 ± 5.6

0.49

Years of education

14.3 ± 2.6

15.0 ± 3.3

0.44

Marital status

 Single

13 (54.2)

8 (33.3)

0.24

 Married

7 (29.2)

14 (58.3)

0.08

 Divorced

2 (8.3)

1 (4.2)

1.00

 Live with a partner

2 (8.3)

1 (4.2)

1.00

 Number of children

0.8 ± 1.4

1.0 ± 1.5

0.61

 Employment status (employed)

9 (37.5)

12 (50.0)

0.56

Childhood trauma measures (CTQ)

 Emotional abuse

16.7 ± 6.1

17.8 ± 5.3

0.50

 Physical abuse

11.2 ± 5.9

9.7 ± 5.5

0.37

 Sexual abuse

15.8 ± 6.6

17.5 ± 5.7

0.35

 Emotional neglect

16.2 ± 5.8

18.8 ± 4.5

0.10

 Physical neglect

10.8 ± 4.3

12.0 ± 4.5

0.39

Fibromyalgia measures

 Wide spread pain index (WPI)

13.9 ± 4.1

13.1 ± 3.9

0.50

 Symptom severity score (SSS)

10.3 ± 1.6

10.5 ± 1.1

0.68

 Past psychotherapy treatment (years)

4.4 ± 3.3

5.2 ± 4.4

0.51

 Past hospitalizations

6 (25.0)

6 (25.0)

1.00

 Previous suicidal attempts

3 (12.5)

4 (16.7)

1.00

Measures of childhood assault

Identity of offender

 Incest (parent of sibling)

14 (58.3)

12 (50.0)

0.77

 Other

10 (41.7)

12 (50.0)

1.00

Frequency of abuse

 Unknown

1 (4.2)

2 (8.3)

1.00

 One time

5 (20.8)

3 (12.5)

0.69

 Multiple

4 (16.7)

9 (37.5)

0.50

 Continuous (> year)

14 (58.3)

10 (41.7)

0.42

 Age of abuse (first memory)

9.5 ± 4.8

6.7 ± 3.8

0.03

Number of offenders

 Single

19 (79.2)

21 (87.5)

0.70

 Multiple

5 (20.8)

3 (12.5)

1.00

Related background medical conditions

 Asthma (childhood)

3 (12.5)

0 (0.0)

0.23

 Hypothyroidism

6 (25.0)

1 (4.2)

0.09

 IBS

3 (12.5)

2 (8.3)

1.00

 Eating disorders

1 (4.2)

3 (12.5)

0.60

 Endometriosis

2 (8.3)

3 (12.5)

1.00

 PCOS/ovarian cyst

1 (4.2)

3 (12.5)

0.60

 ADHD

4 (16.7)

6 (25.0)

0.72

 BMI (kg/m2)

40.1 ± 9.9

36.1 ± 7.3

0.12

Disease-related chronic medications

 Cannabis

7 (29.2)

8 (33.3)

1.00

 Benzodiazepines

4 (16.7)

3 (12.5)

1.00

 Antidepressants

14 (58.3)

9 (37.5)

0.24

 Antipsychotics

4 (16.7)

3 (12.5)

1.00

 Anticonvulsants

4 (16.7)

2 (8.3)

0.66

 Levothyroxine

5 (20.8)

1 (4.2)

0.18

 Attention disorder treatment

2 (8.3)

3 (12.5)

1.00

  1. Data presented as n (%); continuous data, mean ± SD. HBOT Hyperbaric oxygen therapy, IBS irritable bowel syndrome, PCOS polycystic ovary syndrome, ADHD attention-deficit/hyperactivity disorder, BMI body mass index.